Comparative Study of Diffusion-Weighted Imaging Versus Dynamic Contrast Enhanced-MRI in Diagnosis of Breast Tumors
Hina Hanif Mughal, Hina Hafeez Abbasi, Fizza Batool
862
ABSTRACT
Background and Aim: Dynamic
contrast-enhanced magnetic resonance imaging plays a significant role in the
identification and characterization of breast tumors whereas Diffusion-weighted
imaging (DWI) differentiates the benign lesions from malignant lesions. The
present study aims to assess the diagnostic accuracy of dynamic
contrast-enhanced MRI and diffusion-weighted imaging in the diagnosis of breast
tumors.
Methodology:
This cross-sectional study was conducted on 92 suspicious
breast tumors patients underwent Diffusion-weighted imaging (DWI) and Dynamic
contrast-enhanced magnetic resonance imaging in the department of Radiology of
Holy Family Hospital and Benazir Bhutto Hospital, Rawalpindi from
November 2020 to August 2021.DCE-MRI with DWI combination was subjected to morphologic
and kinetic analyses. These findings were compared with standard
histopathological findings.DWI values were used to calculate apparent diffusion
coefficients (ADC). We compared the ADCs of benign and malignant lesions.
Morphologic kinetic features and ADCs were evaluated together for the combined
MRI protocol. DCEMRI, DWI, and combined MRI diagnostic values were computed.
SPSS version 23 was used for statistical analysis.
Results:Out
of 92 suspicious breast tumors, patients who underwent MRI, benign and
malignant were 34 (37%) and 58 (63%) respectively. The overall mean age was
32.56±8.62 years with an age range of 20 to 70 years. Needle biopsy with
percutaneous core was confirmed in all cases (BI-RADS≥3). The common malignant
lesions were in upper outer quadrant 22 (37.9%), upper inner quadrant 11 (19%),
lower outer quadrant 10 (17.2%), and lower inner quadrant 11 (19%). About 4
(6.9%) had malignant lesions in the retro areolar region. Based on quantitative
diffusion coefficient measurement sensitivity, specificity, positive, and
negative predictive value 94%, 81%, 89%, and 92% respectively for differentiating
malignant tumors from benign. The sensitivity and specificity of DCE-MRI were
94% and 76% respectively. The combined sensitivity and specificity of DCE-MRI
and DWI were 96% and 84% which was more significant than DCE-MRI and DWI
alone.
Conclusion: Our study found that benign or malignant
breast lesions can be identified and characterized with high sensitive
multi-parametric MRI of breast. DWI and breast DCE-MRI both has comparable sensitivity.
However, ascompared to DWI and DCE-MRI alone, the breast MRI had higher
sensitivity and specificity in distinguishing malignant breast lesions from
benign lesions.
Keywords:
MRI
breast, Dynamic Contrast-Enhanced (DCE)-MRI, Diffusion-Weighted Imaging (DWI)
ABSTRACT
Background and Aim: Dynamic
contrast-enhanced magnetic resonance imaging plays a significant role in the
identification and characterization of breast tumors whereas Diffusion-weighted
imaging (DWI) differentiates the benign lesions from malignant lesions. The
present study aims to assess the diagnostic accuracy of dynamic
contrast-enhanced MRI and diffusion-weighted imaging in the diagnosis of breast
tumors.
Methodology:
This cross-sectional study was conducted on 92 suspicious
breast tumors patients underwent Diffusion-weighted imaging (DWI) and Dynamic
contrast-enhanced magnetic resonance imaging in the department of Radiology of
Holy Family Hospital and Benazir Bhutto Hospital, Rawalpindi from
November 2020 to August 2021.DCE-MRI with DWI combination was subjected to morphologic
and kinetic analyses. These findings were compared with standard
histopathological findings.DWI values were used to calculate apparent diffusion
coefficients (ADC). We compared the ADCs of benign and malignant lesions.
Morphologic kinetic features and ADCs were evaluated together for the combined
MRI protocol. DCEMRI, DWI, and combined MRI diagnostic values were computed.
SPSS version 23 was used for statistical analysis.
Results:Out
of 92 suspicious breast tumors, patients who underwent MRI, benign and
malignant were 34 (37%) and 58 (63%) respectively. The overall mean age was
32.56±8.62 years with an age range of 20 to 70 years. Needle biopsy with
percutaneous core was confirmed in all cases (BI-RADS≥3). The common malignant
lesions were in upper outer quadrant 22 (37.9%), upper inner quadrant 11 (19%),
lower outer quadrant 10 (17.2%), and lower inner quadrant 11 (19%). About 4
(6.9%) had malignant lesions in the retro areolar region. Based on quantitative
diffusion coefficient measurement sensitivity, specificity, positive, and
negative predictive value 94%, 81%, 89%, and 92% respectively for differentiating
malignant tumors from benign. The sensitivity and specificity of DCE-MRI were
94% and 76% respectively. The combined sensitivity and specificity of DCE-MRI
and DWI were 96% and 84% which was more significant than DCE-MRI and DWI
alone.
Conclusion: Our study found that benign or malignant
breast lesions can be identified and characterized with high sensitive
multi-parametric MRI of breast. DWI and breast DCE-MRI both has comparable sensitivity.
However, ascompared to DWI and DCE-MRI alone, the breast MRI had higher
sensitivity and specificity in distinguishing malignant breast lesions from
benign lesions.
Keywords:
MRI
breast, Dynamic Contrast-Enhanced (DCE)-MRI, Diffusion-Weighted Imaging (DWI)